PMS-ABIRATERONE 250 MG
ABIRATERONE ACETATE : 250 MG · DIN 02492601 · PHARMASCIENCE INC
Health Canada status: MARKETED
What is PMS-ABIRATERONE?
PMS-ABIRATERONE 250 MG contains ABIRATERONE ACETATE : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 02492601, held by PHARMASCIENCE INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 11-Jan-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02492601 |
|---|---|
| Brand name | PMS-ABIRATERONE |
| Generic / active ingredient | ABIRATERONE ACETATE : 250 MG |
| Manufacturer | PHARMASCIENCE INC |
| Strength | 250 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | L02BX03 ABIRATERONE |
| AHFS class | 10:00.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 11-Jan-2021 |
| Original market date | 2021-01-11 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code L02BX03 ABIRATERONE. 17 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-ABIRATERONE FILM COATED TABLETS | 250 MG | TABLET | APOTEX INC | MARKETED | DIN 02491397 |
| APO-ABIRATERONE FILM COATED TABLETS | 500 MG | TABLET | APOTEX INC | MARKETED | DIN 02491400 |
| JAMP ABIRATERONE | 250 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02502305 |
| JAMP ABIRATERONE | 500 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02529629 |
| MAR-ABIRATERONE | 250 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02503980 |
| MAR-ABIRATERONE | 500 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02503999 |
| NAT-ABIRATERONE | 250 MG | TABLET | NATCO PHARMA (CANADA) INC | MARKETED | DIN 02494132 |
| PMS-ABIRATERONE | 500 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02501503 |
| PRZ-ABIRATERONE | 250 MG | TABLET | PHARMARIS CANADA INC | MARKETED | DIN 02540452 |
| PRZ-ABIRATERONE | 500 MG | TABLET | PHARMARIS CANADA INC | MARKETED | DIN 02540460 |
Who else supplies ABIRATERONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ABIRATERONE appears in 304 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.